Clinical Trial: A multicenter, randomized, double-blind, placebo-controlled phase 2 study to evaluate the efficacy and safety of RGT-274-CR capsules in participants with obesity in Chinese population (China)

China, Aug. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A multicenter, randomized, double-blind, placebo-controlled phase 2 study to evaluate the efficacy and safety of RGT-274-CR capsules in participants with obesity in Chinese population'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130711

Registration Time: 2026/08/24

Type: Interventional study

Primary Sponsor: Zhongshan Hospital, Fudan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=322833

Published by HT Digital Content Services with permission from Health Daily Digest....